MCQ Quiz: Prodrugs and Soft Drugs

Prodrugs and soft drugs are strategic pharmaceutical innovations designed to optimize drug therapy. Prodrugs are biologically inactive compounds converted into active drugs after administration, while soft drugs are active compounds designed to undergo predictable and safe inactivation after achieving their therapeutic effect. This quiz evaluates your knowledge of their mechanisms, design, and clinical application as outlined in Pharm.D. coursework, particularly in PHA5439 and PHA5515.

1. What is a prodrug?

  • A. A highly potent drug
  • B. An inactive compound that is metabolized into an active drug
  • C. A controlled substance
  • D. A drug with multiple active metabolites
    Correct answer: B. An inactive compound that is metabolized into an active drug

2. What is a soft drug?

  • A. A drug with low binding affinity
  • B. A drug that is activated by enzymes
  • C. An active drug designed to be inactivated predictably after action
  • D. A drug with low solubility
    Correct answer: C. An active drug designed to be inactivated predictably after action

3. Which of the following is a major advantage of prodrugs?

  • A. Slower onset of action
  • B. Increased water solubility
  • C. Enhanced stability in the GI tract
  • D. Predictable inactivation
    Correct answer: C. Enhanced stability in the GI tract

4. Which of the following is a classic example of a prodrug?

  • A. Morphine
  • B. Codeine
  • C. Atenolol
  • D. Acetaminophen
    Correct answer: B. Codeine

5. What enzyme is commonly responsible for activating ester prodrugs?

  • A. CYP3A4
  • B. Esterases
  • C. UGT
  • D. SULT
    Correct answer: B. Esterases

6. What is a key characteristic of soft drugs?

  • A. They accumulate in tissues
  • B. They undergo enzymatic activation
  • C. They are designed to produce inactive metabolites
  • D. They have poor oral bioavailability
    Correct answer: C. They are designed to produce inactive metabolites

7. Lisdexamfetamine (Vyvanse) is an example of a prodrug used to treat:

  • A. Hypertension
  • B. Asthma
  • C. ADHD
  • D. Depression
    Correct answer: C. ADHD

8. Which of the following best describes the purpose of designing prodrugs?

  • A. To avoid drug resistance
  • B. To enhance drug potency
  • C. To improve pharmacokinetics and reduce toxicity
  • D. To eliminate metabolites
    Correct answer: C. To improve pharmacokinetics and reduce toxicity

9. Prednisolone is the active form of which prodrug?

  • A. Betamethasone
  • B. Cortisol
  • C. Prednisone
  • D. Dexamethasone
    Correct answer: C. Prednisone

10. The concept of soft drugs is most often applied in:

  • A. Oncology
  • B. Dermatology and anesthesiology
  • C. Psychiatry
  • D. Infectious disease
    Correct answer: B. Dermatology and anesthesiology

11. What is the main purpose of soft drug design?

  • A. Slow drug release
  • B. Prolong drug activity
  • C. Achieve rapid therapeutic action and predictable metabolism
  • D. Enhance CNS penetration
    Correct answer: C. Achieve rapid therapeutic action and predictable metabolism

12. Which of the following is a soft drug used in ophthalmology?

  • A. Dipivefrin
  • B. Loteprednol
  • C. Timolol
  • D. Pilocarpine
    Correct answer: B. Loteprednol

13. Prodrugs are often used to overcome:

  • A. Low potency
  • B. High bioavailability
  • C. Poor taste
  • D. Poor membrane permeability
    Correct answer: D. Poor membrane permeability

14. Which of these is a prodrug that requires metabolic activation in the liver?

  • A. Morphine
  • B. Lisinopril
  • C. Enalapril
  • D. Amoxicillin
    Correct answer: C. Enalapril

15. Which route of administration is most suitable for soft drugs?

  • A. Intravenous
  • B. Oral
  • C. Topical
  • D. Sublingual
    Correct answer: C. Topical

16. What is the main enzyme responsible for converting clopidogrel to its active form?

  • A. CYP2C9
  • B. CYP3A4
  • C. CYP2D6
  • D. CYP2C19
    Correct answer: D. CYP2C19

17. Which of the following is NOT a benefit of soft drugs?

  • A. Reduced systemic toxicity
  • B. Predictable deactivation
  • C. Long half-life
  • D. Fewer side effects
    Correct answer: C. Long half-life

18. Valacyclovir is a prodrug of:

  • A. Acyclovir
  • B. Zidovudine
  • C. Lamivudine
  • D. Tenofovir
    Correct answer: A. Acyclovir

19. Which of the following is true about inactive prodrugs?

  • A. They exert immediate pharmacological effects
  • B. They are more potent than their active form
  • C. They require enzymatic conversion to become active
  • D. They have a longer duration of action
    Correct answer: C. They require enzymatic conversion to become active

20. Which soft drug is designed to reduce intraocular pressure?

  • A. Loteprednol
  • B. Timolol
  • C. Dipivefrin
  • D. Dorzolamide
    Correct answer: C. Dipivefrin

21. Soft drugs are designed for which of the following purposes?

  • A. Maximize systemic exposure
  • B. Prevent any metabolism
  • C. Minimize side effects by rapid inactivation
  • D. Increase renal clearance
    Correct answer: C. Minimize side effects by rapid inactivation

22. Which of the following is an example of a prodrug used in chemotherapy?

  • A. Cyclophosphamide
  • B. Methotrexate
  • C. Fluorouracil
  • D. Doxorubicin
    Correct answer: A. Cyclophosphamide

23. The active form of sulfasalazine in the colon is:

  • A. Mesalamine
  • B. Prednisolone
  • C. Acetaminophen
  • D. Budesonide
    Correct answer: A. Mesalamine

24. Why are ester prodrugs often used in drug development?

  • A. Easier to manufacture
  • B. They resist hydrolysis
  • C. To improve lipophilicity and absorption
  • D. To enhance taste
    Correct answer: C. To improve lipophilicity and absorption

25. What class of drugs is often developed as soft drugs to reduce systemic side effects?

  • A. NSAIDs
  • B. Corticosteroids
  • C. Antibiotics
  • D. Opioids
    Correct answer: B. Corticosteroids

26. Which of the following is a characteristic of ideal prodrugs?

  • A. Chemically unstable
  • B. Highly polar
  • C. Stable until metabolized to the active form
  • D. Resistant to enzymatic cleavage
    Correct answer: C. Stable until metabolized to the active form

27. Which of the following best describes a “carrier-linked prodrug”?

  • A. Chemically reactive compound
  • B. Contains a transport system to aid absorption
  • C. Linked to a chemical group that is enzymatically cleaved
  • D. Drug with a long half-life
    Correct answer: C. Linked to a chemical group that is enzymatically cleaved

28. Which pharmacokinetic parameter is most improved by prodrug design?

  • A. Volume of distribution
  • B. Bioavailability
  • C. Protein binding
  • D. Tmax
    Correct answer: B. Bioavailability

29. Soft drug metabolism is usually:

  • A. Non-enzymatic
  • B. Enzyme-independent
  • C. Predictable and enzyme-specific
  • D. Highly variable
    Correct answer: C. Predictable and enzyme-specific

30. A “mutual prodrug” involves:

  • A. Two inactive drugs combined with synergistic action
  • B. An active drug paired with a vitamin
  • C. Combination of two drugs each acting as a promoiety for the other
  • D. A drug with its antidote
    Correct answer: C. Combination of two drugs each acting as a promoiety for the other

31. Remifentanil is classified as a:

  • A. Prodrug
  • B. Soft drug
  • C. Cytotoxic drug
  • D. Long-acting analgesic
    Correct answer: B. Soft drug

32. What is the advantage of converting active drugs into prodrugs for oral delivery?

  • A. Increases renal clearance
  • B. Reduces hepatic metabolism
  • C. Improves solubility and permeability
  • D. Eliminates GI absorption
    Correct answer: C. Improves solubility and permeability

33. Which of the following is not commonly modified in prodrug design?

  • A. Functional groups
  • B. Drug solubility
  • C. Taste masking
  • D. Half-life extension
    Correct answer: D. Half-life extension

34. Which of these drugs is designed to be a soft corticosteroid?

  • A. Prednisone
  • B. Loteprednol
  • C. Hydrocortisone
  • D. Betamethasone
    Correct answer: B. Loteprednol

35. The use of prodrugs in pediatric patients is mainly to:

  • A. Decrease absorption
  • B. Reduce metabolic rate
  • C. Enhance palatability and dosing flexibility
  • D. Prevent hepatic clearance
    Correct answer: C. Enhance palatability and dosing flexibility

36. What is the main difference between prodrugs and soft drugs?

  • A. Only prodrugs are active
  • B. Soft drugs require bioactivation
  • C. Prodrugs are inactive and need activation; soft drugs are active and designed to be inactivated
  • D. Soft drugs are only used in oncology
    Correct answer: C. Prodrugs are inactive and need activation; soft drugs are active and designed to be inactivated

37. Which of the following is true about latanoprost?

  • A. It is a soft steroid
  • B. It is a prodrug used to lower intraocular pressure
  • C. It requires no activation
  • D. It has no side effects
    Correct answer: B. It is a prodrug used to lower intraocular pressure

38. Which metabolic process is crucial for prodrug activation?

  • A. Filtration
  • B. Enzymatic hydrolysis
  • C. Passive diffusion
  • D. Protein binding
    Correct answer: B. Enzymatic hydrolysis

39. Which of the following is NOT a soft drug?

  • A. Loteprednol
  • B. Remifentanil
  • C. Procaine
  • D. Prednisone
    Correct answer: D. Prednisone

40. A major challenge in prodrug design is:

  • A. Enhancing taste
  • B. Predicting rate and site of activation
  • C. Avoiding bioavailability
  • D. Inducing enzyme inhibition
    Correct answer: B. Predicting rate and site of activation

41. What is a typical metabolic fate of soft drugs?

  • A. Active metabolite formation
  • B. Accumulation in adipose tissue
  • C. Rapid conversion to inactive, non-toxic metabolites
  • D. Persistent drug action
    Correct answer: C. Rapid conversion to inactive, non-toxic metabolites

42. Bacampicillin is a prodrug of:

  • A. Amoxicillin
  • B. Ampicillin
  • C. Penicillin G
  • D. Clavulanic acid
    Correct answer: B. Ampicillin

43. Which of these is most commonly added to prodrugs to improve oral bioavailability?

  • A. Chloride
  • B. Phosphate
  • C. Sulfate
  • D. Carbonate
    Correct answer: B. Phosphate

44. Loteprednol is designed to minimize:

  • A. Onset of action
  • B. Systemic corticosteroid side effects
  • C. Intraocular pressure
  • D. CNS penetration
    Correct answer: B. Systemic corticosteroid side effects

45. What is the role of esterases in prodrug activation?

  • A. Prevent hydrolysis
  • B. Oxidize prodrugs
  • C. Cleave ester bonds to release active drug
  • D. Transport prodrugs across membranes
    Correct answer: C. Cleave ester bonds to release active drug

46. What functional group is often modified in prodrug design?

  • A. Alcohols
  • B. Carboxylic acids
  • C. Ketones
  • D. Amines
    Correct answer: B. Carboxylic acids

47. Which prodrug is used to reduce gastrointestinal side effects of its active form?

  • A. Levodopa
  • B. Aspirin
  • C. Sulfasalazine
  • D. Nabumetone
    Correct answer: D. Nabumetone

48. What is the most desired property of soft drugs in clinical use?

  • A. Long half-life
  • B. Rapid and predictable deactivation
  • C. Broad spectrum activity
  • D. CNS stimulation
    Correct answer: B. Rapid and predictable deactivation

49. What is a key design challenge for soft drugs?

  • A. Low potency
  • B. Maintaining activity while allowing controlled inactivation
  • C. Long metabolic pathways
  • D. High molecular weight
    Correct answer: B. Maintaining activity while allowing controlled inactivation

50. Which of the following represents a combination of a prodrug and a soft drug strategy?

  • A. Enalapril
  • B. Loteprednol
  • C. Dipivefrin
  • D. Remifentanil
    Correct answer: C. Dipivefrin

Leave a Comment